---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010333"
form_type: "8-K"
ticker: "HTCR"
cik: "0001892322"
company_name: "HeartCore Enterprises, Inc."
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T15:56:20.794009+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# HeartCore signs 13th Go IPO consulting deal with PharmaBio; $800k fees plus warrant

## Summary
- Signed 13th Go IPO consulting agreement with PharmaBio Corporation, second contract in 2024.
- Expected compensation: $500,000 in initial fees, $300,000 in success fees, and a warrant for 3% of PharmaBio common stock.
- CEO cites recent $9M from warrant sale of a previous Go IPO client; expects 2024 to be strongest year.

## SEC filing metadata
- accession: 0001493152-24-010333
- form_type: 8-K
- ticker: HTCR
- cik: 0001892322
- company_name: HeartCore Enterprises, Inc.
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1892322/000149315224010333/0001493152-24-010333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1892322/000149315224010333/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010333
- JSON: https://secwatch.observer/filing/0001493152-24-010333.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010333.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.